T0 | Treatment phase | T1 | |
---|---|---|---|
Oncologist consultation | X | X | |
Diagnosis | X | ||
G8 score ≤14 | X | ||
Geriatrician consultation | X | X | |
Enlighten consent | X | X | |
Enrollment | X | X | |
CGA | X | X | |
Demographic information | X | X | |
Social isolation | X | X | |
Cognitive status (MMSE and clock drawing test) | X | X | |
Mood status (GDS) | X | X | |
Autonomy (ADL and IADL Score) | X | X | |
Nutritional status (BMI, MNA score and Albumin) | X | X | |
Mobility (OLGT, Gait speed) | X | X | |
Sarcopenia screening (SARC-F, Handgrip test and chair stand test) | X | X | |
If Sarcopenia risk suspected (SARC-F≥4/10), and Muscle strength is impaired, SMI will be measured by (DXA)a | Xa | Xa | |
Radiotherapy treatment (dates, dose delivered and number of fractions) | X | ||
Androgen deprivation therapy (dates, dose delivered, frequency, adverse events) | X |